key: cord-0870104-vm1g4ehm authors: Naoum, Flávio Augusto; Ruiz, Adriana Laridondo Zucareli; Martin, Fernando Henrique de Oliveira; Brito, Tayra Hostalacio Gomes; Hassem, Vitoria; Oliveira, Maria Gabriela de Lucca title: Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID‐19 date: 2020-11-15 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13395 sha: 664468fda192245998e5fe54dc360ef51ea02a7c doc_id: 870104 cord_uid: vm1g4ehm INTRODUCTION: Early diagnosis and identification of potential critical cases for timely treatment are crucial for COVID‐19 patients. The aim of this study was to analyze the diagnostic and prognostic implications of WBC and cell population data (CPD) abnormalities related to COVID‐19 at disease onset. METHODS: Baseline WBC counts and CPD data were analyzed in one hundred COVID‐19 patients presenting to emergency department and subsequently discharged (n = 49), admitted (n = 51) or deceased (n = 22), and in 47 healthy subjects. RESULTS: Lymphopenia and eosinopenia were observed in all COVID‐19 patients, with more intensity in the admitted and deceased groups, that also presented increased WBC and neutrophil counts. On CPD analysis, COVID‐19 was associated with increased volume of neutrophils, lymphocytes, and monocytes, whereas conductivity was decreased for neutrophils and increased for lymphocytes. The ROC curve analysis showed good performance for lymphocyte counts in predicting COVID‐19 diagnosis (AUC = 0.858), for neutrophil counts in predicting admission for COVID‐19 (AUC = 0.744) and for monocytes volume in predicting COVID‐19 diagnosis (AUC = 0.837). CONCLUSION: WBC counts and CPD parameters at disease onset in COVID‐19 patients can improve diagnostic characterization and aid in the discrimination between severe and nonsevere presentations. suffer rapid disease progression and death. In this context, increased neutrophil counts and lymphopenia have been described in COVID-19 patients, with implications toward a worse prognosis. However, these hematological abnormalities are rather imprecise as they may appear in other conventional infections. 3 Comprehensive cell population data (CPD) for subpopulations of WBC are possible with the automatic blood cell analyzer DxH800 (Coulter Inc) , and this has been applied, for instance, to study WBC changes due to acute bacterial infections, G-CSF administration, presence of CD34-positive cells in peripheral blood, degeneration induced by storage and, recently, for COVID-19 diagnostic workup. [4] [5] [6] [7] [8] The aim of this study was to analyze COVID-19-related abnormalities of WBC and CPD at disease onset, and identify parameters capable of discriminating between severe and nonsevere forms, as well as those with high or low risk of mortality. In this retrospective study, a total of 100 baseline samples from adult patients with COVID-19 were analyzed. All patients presented to the emergency department (ED) mainly with fever and respiratory symptoms and the diagnosis was confirmed by RT-PCR. After initial evaluation at ED, 49 patients were discharged as outpatients and 51 admitted. Seventy-seven patients eventually recovered and 22 died from the disease. The control group consisted of 47 samples of healthy subjects with a normal CBC. All samples were anticoagulated with K2EDTA (Sarstedt, S-Monovette ® 2.6 mL K3E tubes). The CBC analysis was performed by the Unicel ® DxH800 automated hematology analyzer (Beckman Coulter) to obtain WBC differential and leukocyte CPD with measurements of volume (VOL), conductivity (COND), and median angle light scatter laser (MALS) by the flow cytometry methodology. WBC and CPD data were compared among four groups: control, COVID outpatient, COVID admitted, COVID deceased. Statistical analyses were conducted using Mann-Whitney's U test for differences. The receiver operator characteristic (ROC) curve on WBC and CPD parameters was used to predict both likelihood of COVID-19 and severity of the disease in terms of area under the curve (AUC) along with the 95% confidence interval. All statistics were performed using SPSS software (version 11.5), and two-tailed P values ≤ 0.05 were considered significant. The protocols of this study were performed in accordance with the ethical standards of the local institutional review board. Baseline WBC and neutrophil counts were increased in patients subsequently admitted or deceased with COVID-19. All COVID-19 groups presented lower baseline counts of lymphocytes and eosinophils as compared to control group, but these counts were even lower in severe and fatal COVID-19 groups (Table 1) . Cell population data analysis of WBC detected changes in volume and conductivity of neutrophils and lymphocytes, and in volume of monocytes of COVID-19 patients. Among COVID-19 groups, neutrophils volume was higher in deceased patients ( Figure 1 ). The ROC curve analysis showed that the AUC for lymphocyte counts in predicting COVID-19 diagnosis was 0.858 (P < .001), with a sensitivity of 81% and specificity of 80% for counts below 1.6 × 10 9 / dL ( Figure 2A ). The AUC for neutrophil counts in predicting admission for COVID-19 was 0.744 (P < .001), with a sensitivity of 69% and specificity of 71% for counts above 5.6 × 10 9 /dL ( Figure 2B ). Among CPD parameters, monocytes volume showed good performance in predicting COVID-19 diagnosis with an AUC of 0.837 (P < .001) and sensitivity of 70% and specificity of 90% for counts above 183 arbitrary units ( Figure 2C ). On practical grounds, the need for reliable and readily accessible biomarkers of COVID-19 is warranted to decide whether to promptly isolate a patient and initiate specific therapies while waiting for confirmatory test results. In this study, we identified easily accessible WBC and CPD parameters that could be used both as diagnostic and prognostic markers at onset of COVID-19. In regard to WBC counts, lymphopenia and eosinopenia were consistently observed in COVID-19 patients, with an intensity that which was comparable to RT-PCR. Here, we showed that increased monocytes volume was a reliable diagnostic marker of COVID-19, regardless of disease severity. The satisfactory performance of this CPD parameter might be related to an acute increase in circulating monocytes size, as these cells are first responders to infections after initial exposure to pathogens. 17 One study showed that CPD parameters for neutrophils were similar among healthy subjects and suspected patients that tested negative or positive for COVID-19. 8 In conclusion, baseline WBC counts and CPD parameters in COVID-19 patients can improve diagnostic characterization and aid in the discrimination between severe and nonsevere presentations. Our results emphasize the need of further efforts to develop accurate admission algorithms to better assist COVID-19 patients. The authors have no competing interests. The data that support the findings of this study are available from the corresponding author upon reasonable request. Flávio Augusto Naoum https://orcid.org/0000-0003-3093-8270 World Health Organization. Clinical management of COVID-19: interim guidance Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention Evaluation of cell population data on the UniCel DxH 800 coulter cellular analysis system as a screening for viral infection in children Quantitative determination of neutrophil VCS parameters by the Coulter automated hematology analyzer: new and reliable indicators for acute bacterial infection Leukocyte cell population analysis from the coulter automatic blood cell analyzer DxH800 to monitor the effect of G-CSF Identification of cell morphology parameters from automatic hematology analyzers to predict the peripheral blood CD34-positive cell count after mobilization Assessment of time-dependent white blood cells degeneration induced by blood storage on automated parameters and morphology examination Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection Eosinopenia and COVID-19 Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A Lymphocyte to monocyte ratio as a screening tool for influenza Biomarkers associated with COVID-19 disease progression COVID-19, ECMO, and lymphopenia: a word of caution Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker Neutrophil volume distribution width: a new automated hematologic parameter for acute infection Elevated monocyte distribution width in COVID-19 patients: the contribution of the novel sepsis indicator Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkers. medRxiv